Generex Biotechnology Corp.

Quick facts

Phase 3 pipeline

• Generex Oral-lyn™ · Diabetes
  Oral-lyn is an oral insulin formulation that delivers insulin through the buccal mucosa to lower blood glucose in diabetes patients.

Phase 2 pipeline

• Buccal insulin spray · Diabetes
  Insulin receptor agonist

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Generex Biotechnology Corp. portfolio CI brief
• Generex Biotechnology Corp. pipeline updates RSS